Cargando…

Smyd3-PARP16 axis accelerates unfolded protein response and vascular aging

Vascular endothelial cell senescence and endoplasmic reticulum (ER) stress induced unfolded protein response (UPR) are two critical contributors to individual aging. However, whether these two biological events have crosstalk and are controlled by shared upstream regulators are largely unknown. Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Di, Wang, Qing, Wei, Gang, Wu, Jiaxue, Zhu, Yi Chun, Zhu, Qing, Ni, Ting, Liu, Xinhua, Zhu, Yi Zhun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695420/ https://www.ncbi.nlm.nih.gov/pubmed/33144524 http://dx.doi.org/10.18632/aging.103895

Ejemplares similares

SMYD3–PARP16 axis accelerates unfolded protein response and mediates neointima formation
por: Long, Fen, et al.
Publicado: (2021)

Histone methyltransferase Smyd3 is a new regulator for vascular senescence
por: Yang, Di, et al.
Publicado: (2020)

Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity
por: Su, Zhenghua, et al.
Publicado: (2022)

SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases
por: Wu, Weijun, et al.
Publicado: (2021)

Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality
por: Sanese, Paola, et al.
Publicado: (2020)

Epigallocatechin-3-gallate enhances ER stress-induced cancer cell apoptosis by directly targeting PARP16 activity
por: Wang, Juanjuan, et al.
Publicado: (2017)

SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells
por: Toghill, Bradley J., et al.
Publicado: (2018)

Histone methyltransferase SMYD2: ubiquitous regulator of disease
por: Yi, Xin, et al.
Publicado: (2019)

PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
por: Ding, Xia, et al.
Publicado: (2022)

Unfolding of core nucleosomes by PARP-1 revealed by spFRET microscopy
por: Sultanov, Daniel, et al.
Publicado: (2017)

Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3
por: Foreman, Kenneth W., et al.
Publicado: (2011)

The SMYD1 and skNAC transcription factors contribute to neurodegenerative diseases
por: Mayfield, R. Dayne, et al.
Publicado: (2020)

PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK and IRE1α-mediated unfolded protein response
por: Jwa, Miri, et al.
Publicado: (2012)

Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
por: Binh, Mai Thanh, et al.
Publicado: (2020)

Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice
por: Cui, Binbin, et al.
Publicado: (2022)

ATM Signaling Pathway Is Implicated in the SMYD3-mediated Proliferation and Migration of Gastric Cancer Cells
por: Wang, Lei, et al.
Publicado: (2017)

Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke
por: Wang, Jinghuan, et al.
Publicado: (2022)

Epigenetics and Vascular Senescence–Potential New Therapeutic Targets?
por: Ding, Qian, et al.
Publicado: (2020)

Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation
por: Zhu, Li, et al.
Publicado: (2023)

The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer
por: Ikram, Sabeen, et al.
Publicado: (2023)

Network analyses elucidate the role of SMYD3 in esophageal squamous cell carcinoma
por: Liu, Xinning, et al.
Publicado: (2017)

ZYZ-772 Prevents Cardiomyocyte Injury by Suppressing Nox4-Derived ROS Production and Apoptosis
por: Wang, Ying, et al.
Publicado: (2017)

Evolutionary History of the Smyd Gene Family in Metazoans: A Framework to Identify the Orthologs of Human Smyd Genes in Drosophila and Other Animal Species
por: Calpena, Eduardo, et al.
Publicado: (2015)

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis
por: Xu, Kangdi, et al.
Publicado: (2022)

SMYD2 Regulates Vascular Smooth Muscle Cell Phenotypic Switching and Intimal Hyperplasia via Interaction with Myocardin
por: Zhou, Yu, et al.
Publicado: (2023)

The discovery of a novel inhibitor of apoptotic protease activating factor-1 (Apaf-1) for ischemic heart: synthesis, activity and target identification
por: Wang, Ying, et al.
Publicado: (2016)

MiR-346 suppresses cell proliferation through SMYD3 dependent approach in hepatocellular carcinoma
por: Zhu, Weiyou, et al.
Publicado: (2017)

PARP16-Mediated Stabilization of Amyloid Precursor Protein mRNA Exacerbates Alzheimer’s Disease Pathogenesis
por: Wang, Jinghuan, et al.
Publicado: (2023)

SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis
por: Ye, Xiangli, et al.
Publicado: (2016)

SMYD proteins in immunity: dawning of a new era
por: Doughan, Maysaa, et al.
Publicado: (2016)

SMYD2 glutathionylation contributes to degradation of sarcomeric proteins
por: Munkanatta Godage, Dhanushka N. P., et al.
Publicado: (2018)

Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
por: Thomenius, Michael J., et al.
Publicado: (2018)

Uncoupling of PARP1 Trapping and Inhibition Using Selective PARP1 Degradation
por: Wang, Shuai, et al.
Publicado: (2019)

Targeting Epigenetic Mechanisms in Vascular Aging
por: Lin, Zhongxiao, et al.
Publicado: (2022)

SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer
por: De Marco, Katia, et al.
Publicado: (2023)

C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis
por: Brown, Mark A., et al.
Publicado: (2015)

Ranunculus ternatus Thunb extract attenuates renal fibrosis of diabetic nephropathy via inhibiting SMYD2
por: Xu, Weiwei, et al.
Publicado: (2022)

Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model
por: Williams, Jamal B., et al.
Publicado: (2023)

Autoimmune response to PARP and BRCA1/BRCA2 in cancer
por: Zhu, Qing, et al.
Publicado: (2015)

Unfolded Protein Response and Cancer
por: Wu, Lihua, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_72656k6q4bb1t1hh5b8urj9dvo